Mckesson and hca healthcare announce plans to form an oncology research joint venture to advance cancer care and increase access to oncology clinical research

Irving, texas & nashville, tenn.--(business wire)--mckesson corporation (nyse: mck) and hca healthcare, inc. (nyse: hca) announced today an agreement to form a joint venture combining mckesson's us oncology research (usor) and hca healthcare's sarah cannon research institute (“scri”). usor is the research arm of mckesson's the us oncology network and draws from a network of experienced investigators and dedicated clinical staff who specialize in oncology clinical trials. scri, which is the rese
MCK Ratings Summary
MCK Quant Ranking